{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:39:19Z","timestamp":1791031159475,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/mop.0b013e3283557d4c","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T07:00:43Z","timestamp":1339743643000},"page":"498-504","source":"Crossref","is-referenced-by-count":54,"title":["Marfan syndrome"],"prefix":"10.1097","volume":"24","author":[{"given":"Nikhita","family":"Bolar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lut","family":"Van Laer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L.","family":"Loeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210206","first-page":"220","article-title":"A case of congenital malformation of the four limbs, most pronounced in the extremities, characterized by an extension of the bones with a certain degree of slimming (in French).","volume":"13","author":"Marfan","year":"1886","journal-title":"Bulletins et memoires de la Societe medicale des Hopitaux de Paris"},{"key":"R2-12-20210206","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"R3-12-20210206","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"R4-12-20210206","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome.","volume":"114","author":"Judge","year":"2004","journal-title":"J Clin Invest"},{"key":"R5-12-20210206","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"R6-12-20210206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/ng1511","article-title":"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.","volume":"37","author":"Loeys","year":"2005","journal-title":"Nat Genet"},{"key":"R7-12-20210206","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajmg.1320290316","article-title":"International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986.","volume":"29","author":"Beighton","year":"1988","journal-title":"Am J Med Genet"},{"key":"R8-12-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R","article-title":"Revised diagnostic criteria for the Marfan syndrome.","volume":"62","author":"De Paepe","year":"1996","journal-title":"Am J Med Genet"},{"key":"R9-12-20210206","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome.","volume":"47","author":"Loeys","year":"2010","journal-title":"J Med Genet"},{"key":"R10-12-20210206","first-page":"433","article-title":"The new Ghent criteria for Marfan syndrome: what do they change Clin G","volume":"81","author":"Faivre","year":"2012","journal-title":"enet"},{"key":"R11-12-20210206","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1399-0004.2011.01646.x","article-title":"Critical appraisal of the revised Ghent criteria for diagnosis of Marfan syndrome.","volume":"80","author":"Radonic","year":"2011","journal-title":"Clin Genet"},{"issue":"A","key":"R13-12-20210206","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajmg.a.34392","article-title":"A comparison of the Ghent and revised Ghent nosologies for the diagnosis of Marfan syndrome in an adult Korean population.","volume":"158","author":"Yang","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"A","key":"R14-12-20210206","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.a.34386","article-title":"The 8th International Research Symposium on the Marfan Syndrome and related conditions.","volume":"158","author":"Pyeritz","year":"2012","journal-title":"Am J Med Genet A"},{"key":"R15-12-20210206","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.934","article-title":"Genome-wide association study identifies a susceptibility locus for thoracic aortic aneurysms and aortic dissections spanning FBN1 at 15q21.1.","volume":"43","author":"Lemaire","year":"2011","journal-title":"Nat Genet"},{"key":"R16-12-20210206","doi-asserted-by":"crossref","first-page":"23ra20","DOI":"10.1126\/scitranslmed.3000488","article-title":"Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome.","volume":"2","author":"Loeys","year":"2010","journal-title":"Sci Transl Med"},{"key":"R17-12-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ng.1016","article-title":"Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome.","volume":"44","author":"Le Goff","year":"2012","journal-title":"Nat Genet"},{"key":"R18-12-20210206","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/ajmg.a.33909","article-title":"Nosology and classification of genetic skeletal disorders: 2010 revision.","volume":"155A","author":"Warman","year":"2011","journal-title":"Am J Med Genet A"},{"key":"R19-12-20210206","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajhg.2011.05.012","article-title":"Mutations in the TGFbeta binding-protein-like domain 5 of FBN1 are responsible for acromicric and geleophysic dysplasias.","volume":"89","author":"Le Goff","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R20-12-20210206","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/ng.199","article-title":"ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation.","volume":"40","author":"Le Goff","year":"2008","journal-title":"Nat Genet"},{"key":"R21-12-20210206","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor.","volume":"355","author":"Loeys","year":"2006","journal-title":"N Engl J Med"},{"key":"R22-12-20210206","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ejhg.2010.45","article-title":"Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency.","volume":"18","author":"Renard","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"R23-12-20210206","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/nature10145","article-title":"Lessons on the pathogenesis of aneurysm from heritable conditions.","volume":"473","author":"Lindsay","year":"2011","journal-title":"Nature"},{"key":"R24-12-20210206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jmedgenet-2011-100382","article-title":"Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome.","volume":"49","author":"van de Laar","year":"2012","journal-title":"J Med Genet"},{"key":"R25-12-20210206","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice.","volume":"332","author":"Holm","year":"2011","journal-title":"Science"},{"key":"R26-12-20210206","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1126\/science.1192152","article-title":"Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.","volume":"332","author":"Habashi","year":"2011","journal-title":"Science"},{"key":"R27-12-20210206","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfans syndrome.","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"key":"R28-12-20210206","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ahj.2007.06.024","article-title":"Rationale and design of a randomized clinical trial of beta-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome.","volume":"154","author":"Lacro","year":"2007","journal-title":"Am Heart J"},{"key":"R29-12-20210206","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.acvd.2010.04.008","article-title":"Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome.","volume":"103","author":"Detaint","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"R30-12-20210206","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2459\/JCM.0b013e3283232a45","article-title":"Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.","volume":"10","author":"Gambarin","year":"2009","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R31-12-20210206","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijcard.2010.12.070","article-title":"The Ghent Marfan Trial: a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with beta-blockers.","volume":"157","author":"Moberg","year":"2012","journal-title":"Int J Cardiol"},{"key":"R32-12-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1745-6215-11-3","article-title":"Losartan therapy in adults with Marfan syndrome: study protocol of the multicenter randomized controlled COMPARE trial.","volume":"11","author":"Radonic","year":"2010","journal-title":"Trials"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e3283557d4c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:42:15Z","timestamp":1620949335000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201208000-00012"}},"subtitle":["from gene to therapy"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e3283557d4c","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}